Putnam BioRevolution ETF Rating $30.07 +0.16 (+0.53%) (As of 11/20/2024 ET) Add Compare Share Share Ratings Stock AnalysisChartHoldingsRatings Putnam BioRevolution ETF Aggregate Rating and Price Target (2024)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.SYNB Aggregate RatingModerate Buy 2.78Holdings in SYNB have an aggregate rating of Moderate Buy based on 563 analyst ratings issued in the past year covering 31 companies (85.9% of the portfolio).SYNB Aggregate Price Target$30.07High Prediction$30.07Average Prediction$30.07Low Prediction$30.07Holdings in SYNB have an aggregate price target of $30.07 and a range of $30.07 to $30.07 covering 31 companies (85.9% of the portfolio).SYNB Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy1 Buy rating(s)Moderate Buy28 Moderate Buy rating(s)Hold2 Hold rating(s)Reduce0 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by Putnam BioRevolution ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 31 SYNB Holdings Export to ExcelWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings6.93%TMOThermo Fisher Scientific$514.13+0.3%4.9906 of 5 stars2.86$649.33 26.3%22Buyback AnnouncementPositive News6.50%DHRDanaher$233.99+0.4%4.9362 of 5 stars2.74$287.16 22.7%19Analyst DowngradePositive News5.23%NVDANVIDIA$147.96+1.4%4.9341 of 5 stars2.93$160.82 8.7%44Earnings ReportDividend AnnouncementAnalyst ForecastAnalyst RevisionNews CoverageGap Up5.21%BIOBio-Rad Laboratories$325.32+0.5%4.7349 of 5 stars2.60$391.80 20.4%5Positive News4.67%GOOGLAlphabet$166.50-5.4%4.5818 of 5 stars2.93$205.90 23.7%42Short Interest ↓Analyst Revision4.40%CTVACorteva$60.82+3.5%4.3656 of 5 stars2.67$64.26 5.7%21Analyst ForecastBuyback Announcement4.06%ABBVAbbVie$171.85+2.4%4.9638 of 5 stars2.90$203.37 18.3%21Analyst ForecastPositive News3.81%LLYEli Lilly and Company$750.62-0.4%4.9913 of 5 stars2.81$1,007.94 34.3%21Analyst Revision3.67%DDDuPont de Nemours$82.99+1.4%4.409 of 5 stars2.54$95.42 15.0%13News CoveragePositive News3.64%ASNDAscendis Pharma A/S$123.86-0.4%3.0193 of 5 stars2.92$191.77 54.8%13Analyst Upgrade3.61%REGNRegeneron Pharmaceuticals$748.22+0.7%4.8024 of 5 stars2.78$1,099.55 47.0%23Positive News3.43%EXASExact Sciences$53.47+1.5%4.8884 of 5 stars2.95$74.47 39.3%19Analyst ForecastPositive News3.02%ZTSZoetis$177.18+0.9%4.8704 of 5 stars3.10$221.44 25.0%10Positive News2.93%AZNAstraZeneca$63.71+0.8%3.9932 of 5 stars2.92$89.75 40.9%12Analyst UpgradeAnalyst Revision2.71%AVTRAvantor$20.38+1.2%4.9775 of 5 stars2.80$27.57 35.3%15Analyst Revision2.29%DARDarling Ingredients$41.47-0.7%4.2269 of 5 stars2.78$53.44 28.9%9Positive News2.21%CDNSCadence Design Systems$307.04+1.0%4.6082 of 5 stars2.77$326.00 6.2%13Positive News1.80%ONONON$56.35+4.9%2.4547 of 5 stars2.87$55.14 -2.1%23Analyst UpgradeGap Up1.74%BIIBBiogen$158.18+1.4%4.8674 of 5 stars2.54$257.20 62.6%28Analyst Downgrade1.68%NGVTIngevity$48.24+4.3%2.5856 of 5 stars2.50$52.17 8.1%6Positive News1.65%PPGPPG Industries$122.43+0.9%4.4249 of 5 stars2.65$149.93 22.5%17Analyst UpgradePositive News1.48%TWSTTwist Bioscience$42.19+2.6%4.15 of 5 stars2.67$51.78 22.7%9Analyst ForecastAnalyst RevisionNews Coverage1.34%VRTXVertex Pharmaceuticals$450.27-0.2%4.0563 of 5 stars2.53$499.12 10.8%30Analyst DowngradeNews CoveragePositive News1.33%BGBunge Global$88.63+0.6%4.643 of 5 stars2.63$118.00 33.1%8Ex-Dividend1.30%ARGXargenx$588.46-0.6%2.8331 of 5 stars2.91$630.42 7.1%23Analyst Forecast1.26%TECHBio-Techne$70.36+2.4%4.8609 of 5 stars2.67$81.78 16.2%91.09%MEDPMedpace$340.65+4.5%4.7436 of 5 stars2.45$380.00 11.6%111.06%ALNYAlnylam Pharmaceuticals$247.73-0.4%4.4125 of 5 stars2.71$298.09 20.3%24Analyst Forecast0.80%BMRNBioMarin Pharmaceutical$63.10+0.9%4.9884 of 5 stars2.74$94.20 49.3%23Analyst Revision0.67%RCKTRocket Pharmaceuticals$13.12+0.6%4.4279 of 5 stars2.91$51.00 288.7%11Analyst ForecastAnalyst Revision0.38%CRSPCRISPR Therapeutics$46.34-1.9%1.7975 of 5 stars2.37$74.94 61.7%19 This page (NYSEARCA:SYNB) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredThe pin that pops the AI bubbleMy new documentary explores the background to this pattern and how and why I believe it will almost certainly ...Porter & Company | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Putnam BioRevolution ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Putnam BioRevolution ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
